Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB Forum Quarterly Review, eFiles Tag and CEI Report Q4/2024
-
Good Morning @Manufacturer and @Agency
Hope everyone is staying warm and enjoying the
️.The PAAB Quarterly Tag and CEI Reports have been updated to contain data for Q4. See the Tag report here and the CEI report here.
The Forum Quarterly Review for Q4 has also been posted.
These wrap up 2024! Thank you for another great year of collaboration and compliance. We hope to continue working with you in 2025
Thank you
PAAB
